The Business Journals

Denali Therapeutics is losing Carole Ho, as she heads to Lilly as head of neuroscience

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Ho, formerly of Genentech, was a ...